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Host-Adaptation of Burkholderia 
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and Virulence: a Global Proteome 
Analysis
Vanitha Mariappan, Kumutha Malar Vellasamy & Jamuna Vadivelu
Little is known about the evolution, adaptation and pathogenesis of Burkholderia pseudomallei within 
host during acute melioidosis infection. Melioidosis is a potential life threatening disease contracted 
through inhalation, ingestion, inoculation or direct entry of the organism into the blood stream via 
wounds or skin abrasions from contaminated soil and water. Environmental B. pseudomallei strain 
(BpMARAN), isolated during a melioidosis outbreak in Pahang, Malaysia was injected intra-peritoneally 
into a mouse and passaged strain was recovered from spleen (Bpmouse-adapted). A gel-based comparative 
proteomics profiling approach was used, to map and identify differentially expressed proteins (fold-
change ≥ 2; p-value ≤ 0.05) between the strains. A total of 730 and 685 spots were visualised in the 
BpMARAN and Bpmouse-adapted strains, respectively. Of the 730 spots (BpMARAN as reference gel), 87 spots 
were differentially regulated (44 up- and 43 down-regulated). The identified proteins were classified 
as proteins related to metabolism, stress response, virulence, signal transduction, or adhesion. In 
comparison, it was found that those proteins related to adhesins, virulence factors and stress- response 
were up-regulated and could possibly explain the adaptation of the bacteria in the host. Investigating 
the differentially expressed proteins may provide better perspective of bacterial factors which aid 
survivability of B. pseudomallei in host.
Knowledge on the evolution and adaptation of intracellular bacteria within host during acute infection is still 
equivocal. The exact pathogenic mechanisms of disease caused by these bacteria are still not completely under-
stood, especially the interaction between the host and the pathogen that results in an initial infections. The 
question on how intracellular bacteria adapt to the host environment and cause disease remains a challenge to 
researchers. Thus, we are interested to investigate the evolution during host-adaptation of intracellular bacteria 
Burkholderia pseudomallei, a free living saprophyte found in the soil and contaminated water. This bacterium is 
the causative agent of melioidosis and is commonly found in tropical and subtropical regions and endemic in 
Southeast Asian countries and northern Australia1, 2. The mode of transmission is through inhalation, ingestion, 
inoculation or direct entry of the organism into the blood stream via wounds or skin abrasions3. It is noteworthy 
to mention that to date, there is no vaccine has been invented to prevent the disease4.
B. pseudomallei is also known to produce exoenzymes, adhere, colonise, invade, replicate and survive intra-
cellularly in the host cells5, 6. Due to the severe infection rate, aerosol infectivity and intrinsic resistant to a large 
number of antimicrobial agents, B. pseudomallei has been classified as a potential agent for bioterrorism (Tier 1 
agent) by the U. S. Centers for Disease Control and Prevention and melioidosis has been indicated as an emerg-
ing infectious disease7, 8. Melioidosis manifest various clinical appearances ranging from chronic pneumonia, 
asymptomatic infection, multiple internal organ abscesses to septic shock9–11. Among the interesting features of 
B. pseudomallei infection is their ability to remain persistent with high rate of relapse incidence despite prolonged 
and appropriate antibiotic treatment11.
Investigations on the protein expression of the bacterium pre- and post-mouse-adaptation may provide better 
understanding of the role of the differentially expressed B. pseudomallei proteins that may be involved in patho-
genesis of melioidosis. Therefore, B. pseudomallei isolated from soil would be an ideal choice of strain selection 
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than a clinical strain as the strain has not adapted through a living system and compromised with immune 
responses. Although not a natural host for B. pseudomallei, mouse infection models play an important role in 
establishing the immunology and pathogenicity of B. pseudomallei.
Thus, experimental animal models that mimic human diseases are essential to provide information on etio-
pathogeny, immunity and therapy, as well as to improve our understanding on ways B. pseudomallei can induce a 
diverse range of diseases. Among various animal models available, mouse remains the most readily used animal 
model for studying B. pseudomallei-induced diseases and have known to play important roles in the elucidation 
of factors required for colonisation, distribution and persistence of infection12. Thus, in this study, it is of interest 
we analysed the B. pseudomallei protein factors potentially involved in the pathogen colonisation progression by 
using 2-DE and MALDI-TOF/TOF mass spectroscopy to perform a global comparative proteomic analysis of the 
B. pseudomallei obtained from soil and its derivate passaged through host immune system. This may shed light 
on a detailed understanding of the evolution and adaptation of B. pseudomallei within the host during infection. 
This will no doubt aid in identification of novel proteins related to the pathogenesis of disease that can be further 
utilized for clinical benefits in terms of diagnosis, protein markers or even vaccine development.
Methods
Bacterial strains, cell lines and culture conditions. The B. pseudomallei MARAN (BpMARAN), iso-
lated from soil at Lubuk Yu, Maran, Pahang, during a melioidosis outbreak was obtained from Institute of 
Medical Research (IMR), Kuala Lumpur, Malaysia. This strain was identified as B. pseudomallei using API 20NE 
(Biomerieux, France), Ashdown agar13 and an in-house PCR using specific primers14. The bacterial cultures of 
BpMARAN and B. pseudomallei MARAN mice-adapted strains (Bpmouse-adapted) were prepared using Luria-Bertani 
(LB) broth according to protocols earlier described15. The bacterial growth curve and viable counts were per-
formed according to Mariappan et al.16 in three independent experiments. The human epithelial cell line, A549, 
cells were obtained from the American Type Culture Collection (Manassas, VA) and grown in Roswell Park 
Memorial Institute (RPMI) medium supplemented with 10% fetal calf serum (FCS). The cell line was grown 
under an atmosphere of 5% CO2.
Determination of 50% lethality dosage (LD50). For the virulence assessment, determination of LD50 
was performed using five BALB/c mice (six-weeks to eight-weeks old) per group, which were intraperitoneally 
challenged with a 100 μl suspension of a diluted mid-logarithmic phase culture of BpMARAN and Bpmouse-adapted 
corresponding to 104 to 107 CFU/ml. A group of five mice injected with sterile PBS were used as negative control. 
The mice were monitored daily (twice a day) and the number of dead mice in each group was determined up to 21 
days post-infection. The LD50 values were calculated based on three independent experiments. The animal work 
was carried out in accordance with the approved guidelines by Association for Assessment and Accreditation 
of Laboratory Animal Care (AAALAC) International and the animal experimental protocols were approved 
by University of Malaya Institutional Animal Care and Use Committee [Animal Ethics: 2014-08-05/MMB/R/
JSV]. Mice were euthanised according to pre-determined humane end point protocols supplied by the University 
Malaya IACUC at the end of the test duration.
Mice infection of B. pseudomallei. Six six-weeks-old pathogen free male BALB/c mice were challenged 
via the intraperitoneal route with 105 CFU/ml of BpMARAN culture resuspended in phosphate buffered saline 
(PBS). The mice were sacrificed on day-three and the spleen was harvested. The spleen was homogenised with 
sterilised PBS and the supernatant was inoculated onto an Ashdown agar. A single colony of the Bpmouse-adapted 
strain was confirmed using API 20NE and an in-house PCR using specific primers. Spleens of the unchallenged 
mice were used as negative control.
Adherence and invasion assays. The adherence and invasion assays were preformed according to 
Mariappan et al.16, 17 with slight modifications. The A549 cells were infected with BpMARAN and Bpmouse-adapted 
strains grown to mid-logarithmic phase. The bacterial cultures were centrifuged at 8,000 X g for 5 mins and 
the resulting pellet was incubated at 37 °C in 1 ml of RPMI for 30 mins. The amount of bacterial inoculum was 
standardised to ~1 × 108 cfu/ml. Confluent monolayers of A549 cells were infected with the bacterial inoculum at 
multiplicity of infection (MOI) of 1:10 and incubated for 2 hrs at 37 °C in 5% CO2 to allow bacterial invasion. The 
monolayers were then washed using 100 mM PBS (pH 7.0), after which 3 ml of RMPI containing a combination 
of kanamycin (1 mg/ml) and gentamicin (1 mg/ml) was added into each well and incubated for 2 hrs at 37 °C to 
kill extracellular bacteria. Following incubation, the monolayers cells were washed three times with PBS and in 
addition, the final volume of PBS used to wash the monolayers was collected and plated on a nutrient agar to 
determine the number of live extracellular bacteria. The monolayer cells were then lysed with 0.25% Triton X-100 
prepared in PBS to quantitate the intracellular bacteria. Serially diluted lysate were plated on NA to determine 
the bacterial colony counts18. This experiment was performed in triplicates and the results were averaged. A 
non-invasive strain of Escherichia coli strain, was used as a negative control.
Biofilm formation assay. Quantitative biofilm formation assay was performed using crystal violet staining 
method as described previously by Ramli et al.19. Briefly, 1 µl of a bacterial culture was added into 100 µl of LB 
broth in each well of a sterile 96-well plate and incubated at 37 °C for 18 hrs, after which, 1 µl of culture from each 
well was transferred into a new 96-well plate containing 100 µl of fresh LB broth and further incubated at 37 °C for 
18 hrs. Following incubation, the supernatant was removed and the wells were stained with 150 µl of 1% crystal 
violet for 30 mins. The stains was removed by washing the wells twice with 175 µl sterile distilled water and DMSO 
(175 µl) was added to each well and absorbance was measured at 570 nm.
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Total bacterial protein extraction. The total bacterial proteins extraction was performed accord-
ing to Al-Maleki, et al.20 with slight modifications in three independent experiments. Briefly, the BpMARAN and 
Bpmouse-adapted strains grown as described earlier15 to mid-logarithmic phase were centrifuged at 4 °C, 4,500 X g 
for 30 mins. The resulting bacterial pellets were washed with cold PBS, and resuspended in 1 ml of lysis buffer16. 
Subsequently, the bacterial cells were sonicated on ice at 22% amplitude at 1 s pulse intervals for 3 mins using an 
Ultrasonic Homogenizer (Omni Ruptor 4000, USA). The lysate was then centrifuged at 14,000 X g for 5 mins at 
4 °C and the supernatants were collected, aliquated and stored at −80 °C until use. The total protein concentra-
tions were determined using the Bradford protein assay method21.
Two-dimensional gel electrophoresis (2-DE) and image analysis. The two-dimensional gel electro-
phoresis was performed according to Vellasamy et al.22. Briefly, a total of 450 μg protein sample with the rehydra-
tion buffer (8 M urea, 2% CHAPS, 0.002% bromophenol blue) was applied onto the IPG strips (pH 3–10, 13 cm) 
(GE Healthcare, Uppsala, Sweden) and rehydrated under mineral oil for 18 hrs. The proteins on the IPG strips 
were focused using an IPGphor system (GE Healthcare, Uppsala, Sweden). The strips were then transferred onto 
12% SDS-PAGE for the second dimension electrophoresis. The resulting gels were stained using Hot Coomassie 
blue staining method (GE Healthcare, Uppsala, Sweden). Three independent biological growth experiments were 
performed to increase reproducibility of the results. The gels were scanned with an Image Scanner and ana-
lysed using the Progenesis SameSpot (Nonlinear Dynamics, Durham, NC). The gels of BpMARAN and Bpmouse-adapted 
strains were compared and protein spots demonstrating changes in protein expression with a fold change ≥ 2 
(p-value ≤ 0.05; ANOVA) as the threshold values for differential expression were then identified.
Protein identifications and MALDI-TOF MS/MS analysis. Selected protein spots of interest were 
excised and pooled from the stained 2-DE gels and digested with solution of sequencing-grade modified trypsin 
(Promega, Madison, USA). The peptides released from the gel plugs were then sent to the Australian Proteome 
Analysis Facility, Australia for further analysis using MALDI-TOF/TOF MS (4800 Proteomics Analyzer, AB 
Sciex). The subsequent search settings were used: carboxymidomethylation of cysteine was fixed modification 
and oxidation of methionine was selected as variable modification; maximum number of missed cleavages: 1; 
peptide tolerance (peptide tol): ±0.6; peptide charge: +1.
Protein identification and in silico analysis. The mass spectrometry of the proteins was identified 
using the MASCOT search engine (Matrix Science, London, UK). All searches were performed against the 
non-redundant NCBI library (http://ncbi.nlm.nih.gov) database comprising annotated proteins of B. pseudom-
allei K96243 as reference. The identified proteins were assigned into functional classes of based on Cluster of 
Orthologous Groups (COG) (http://www.ncbi.nlm.nig.gov/COG/old/palox.cgi?fun=all) and Gene Ontology 
(http://omictools.com/gene-set-analysis) for the proteins functional categories. The bioinformatics database 
(www.cds.dtu.dk) was used to predict the mode of secretion (SignalP v3.0), cellular localisation (PSORT) and 
protein domains (TMHMM v2.0). The bacterial pathways of the significantly differentially expressed genes (stu-
dent’s t-test) were analysed using the Kyoto Encyclopaedia of Genes and Genomes (KEGG) database (http://www.
genome.jp/kegg/).
Quantitative real-time PCR (qRT-PCR). The qRT-PCR was performed utilizing CFX96 Touch Real-Time 
PCR Detection System (BioRad Laboratories, USA), to verify and quantify the expression of ompW, groL, EF-Tu, 
extracellular ligand binding protein, katG, Hsp, hypothetical protein BPSS1107and BPSL1958, with 50S and 30S 
ribosomal protein as reference housekeeping gene (Table S1). Briefly, 25 µl reactions were performed using the 
iScript™OneStep RT-PCR kit with SYBR green according to the manufacturer’s instruction (BioRad Laboratories, 
USA), primers at a final concentration of 1 µM and a data acquisition temperature of 56 °C. In order to control 
the variation in RNA concentration, cycle threshold (Ct) values were normalised to housekeeping genes that does 
not change with infection. The CFX real-time PCR software (Biorad, California, USA) was used to generate the 
quality control of the replicates, data extraction and initial analysis with a manual threshold of 0.6 and an auto 
baseline applied in order to obtain the threshold cycle (Ct) value for each measurement taken.
Results
Mice Burkholderia pseudomallei infection model. The growth profile of both strains were studied and 
revealed almost similar prolife in a nutrient rich medium under an aerobic condition (Supplementary Fig. S1). In 
this study, BALB/c mice were infected with BpMARAN and Bpmouse-adapted strains via the intraperitoneal route. Based 
on the LD50 (Supplementary Fig. S2), the time to achieve 100% death from 107 CFU/ml of BpMARAN was in two 
days; while with 106 only one mouse survived on day 16. Approximately 60% of mice injected with 104 CFU/ml 
survived until day 12. The LD50 of BpMARAN and Bpmouse-adapted are 104 and 104.6 CFU/ml, respectively. It was found 
that upon infection, the mice infected with a dosage of >104 CFU/ml of BpMARAN and Bpmouse-adapted displayed 
symptoms of disease such as lethargy and had dishevelled fur before succumbed to infection. Two and three of the 
mice infected with BpMARAN and Bpmouse-adapted survived up to 21 days, respectively. Overall, BpMARAN was found to 
be highly virulent than the Bpmouse-adapted strain.
Ability of BpMARAN and Bpmouse-adapted strains to adhere and invade theA549 epithelial cells. We 
further investigated the ability of BpMARAN and Bpmouse-adapted strains (mid-logarithmic phase) to adhere and invade 
into the A549 cells (Table 1). Generally, percentage of adherence increased in similar trend for both the strains 
corresponding with the time of infection. At 2 hrs and 4 hrs post-infection, there were no obvious differences 
observed in the number of BpMARAN and Bpmouse-adapted adhered to the A549 cells (2.22 ± 0.96% and 16.67 ± 0%, 
respectively). The mean percentage of adherence of BpMARAN and Bpmouse-adapted increased significantly from 6 hrs 
to 8 hrs with 2-fold and 1.5- fold changes, respectively. Overall, the percentage of adherence of Bpmouse-adapted was 
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noticeably higher than the BpMARAN. In addition, the invasion profile was somehow similar to the adherence pro-
file, where significant differences between these strains were observed at 6 hrs of post-infection. In general, the 
mean percentage of BpMARAN invasion was lower (0.2–0.3 fold) compared to the Bpmouse-adapted. Taken as a whole, 
the percentage of adherence and invasion were found to be strain-dependent.
Aptitude of BpMARAN and Bpmouse-adapted strains to produce of biofilm. To investigate whether both 
BpMARAN and Bpmouse-adapted strains are able to form biofilm at different temperatures, we determined the produc-
tion the biofilm using the colorimetric method. In general, both the strains were found to produce biofilm at both 
30 °C and 37 °C (Fig. 1). However, there were no significant differences observed in biofilm formation between 
BpMARAN and Bpmouse-adapted strains at 30 °C and 37 °C. At 37 °C, the production of BpMARAN biofilm appeared to be 
increased (OD570nm 0.384) as compared to the Bpmouse-adapted (OD570nm 0.291).
Overview and comparative proteome analysis of BpMARAN and Bpmouse-adapted strains. In order 
to determine the protein expressions of these strains, we performed a comparative proteome analysis. Figure 2 
shows the overview of whole bacterial BpMARAN (panel A) and Bpmouse-adapted (panel B) 2-DE proteome profiles 
harvested from cultures grown at mid-logarithmic. The gel-based proteomics profiling approach was used to 
map and identify the differentially expressed proteins (fold change ≥ 2; p-value ≤ 0.05) between both the strains. 
A total of 730 and 685 protein spots were visualised from BpMARAN and Bpmouse-adapted, respectively. Approximately 
594 spots were found to be present between the two strains.
However, of the 730 protein spots detected from the BpMARAN (reference gel), 87 protein spots were dif-
ferentially regulated as compared to Bpmouse-adapted. Among these 87 protein spots, 44 spots were significantly 
up-regulated (fold change 2.0–12.2) and 43 were significantly down-regulated (fold change 2.0–6.9).
Of the 87 differentially regulated protein spots detected in the 2-DE profiles, only 83 (44 up-regulated and 
39 down-regulated protein spots) were subsequently identified using MS and database search (Table 2). The 
remaining 4 protein spots were of low abundance and in insufficient quantities for the MALDI-TOF/TOF analy-
sis. Overall, 44 up-regulated protein spots corresponding to 37 different proteins and 39 down-regulated protein 
spots corresponding to 25 proteins were identified. Following that, several proteins were found to be isoforms 
of the same proteins, i.e. DnaK, KatG, gltI, acetoacetyl-CoA reductase and hypothetical protein BPSS1924 (two 
isoforms); atpD and hypothetical protein BPSL1125 (three isoforms); Hsp (four isoforms); GroEL (six isoforms); 
EF-Tu (seven isoforms). It was noticeable that seven protein spots corresponding to five proteins [EF-Tu (n = 3), 
DnaK, Hsp, hypothetical protein BPSS1107 and hypothetical protein BPSS1158] were found to be absent from 
Time 
(Hours)
Adherence (%) Invasion (%)
BpMARAN Bpmouse-adapted BpMARAN Bpmouse-adapted
2 2.22 ± 0.96 2.22 ± 0.96 0.07 ± 0.05 0.10 ± 0.04
4 16.67 ± 0 16.67 ± 0 0.42 ± 0.28 0.47 ± 0.21
6 22.78 ± 1.83* 28.89 ± 1.92* 0.98 ± 0.09* 1.26 ± 0.11*
8 25.22 ± 2.89* 32.11 ± 1.25* 2.47 ± 0.87 3.50 ± 0.3
Table 1. Mean percentage of Burkholderia pseudomallei MARAN and mouse-adapted adherence and invasion. 
Foot note: *p-value ≤ 0.05.
Figure 1. Biofilm formation of BpMARAN and Bpmouse-adapted at 30 °C and 37 °C using crystal violet method. The 
experiments were conducted in three independent replicates (the error bars indicate the standard deviation and 
the significance has been indicated using*).
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BpMARAN, but present in Bpmouse-adapted. In contrast, 13 protein spots corresponding to 12 proteins [clpB, katG 
(n = 2), Alededh, PotF, PcaF, OmpW, Ppa, PixA, GroEL, MetX, ArgC and extracellular ligand binding protein] 
were found to be missing from Bpmouse-adapted, but present in BpMARAN.
Identification of differently expressed BpMARAN and Bpmouse-adapted proteins. Among the 83 differ-
ently regulated proteins identified, 58 proteins (69.9%) were identified to be located in the cytoplasmic region, 
nine proteins (10.8%) from the periplasmic compartment and 13 proteins (15.7%) had no known location. 
However, Cbp, SdhB, and OmpW were predicted to be located at extracellular, cytoplsmic membrane, and outer 
membrane, respectively (Fig. 3).
Of the five missing proteins from BpMARAN, three proteins (EF-Tu, DnaK, and hypothetical protein BPSS1107) 
were located at cytoplasmic region and two proteins (Hsp and hypothetical protein BPSS1158) were predicted 
to be present at unknown location. However, out of the 12 proteins which were found to be missing from 
Bpmouse-adapted, eight proteins (ClpB, KatG, Alededh, PcaF, Ppa, GroEL, MetX and ArgC) were located at the cyto-
plasmic region, two proteins (PotF and extracellular ligand binding protein) at the periplasmic, OmpW were 
located at the outer membrane and PixA, is a protein with unknown location.
Further investigation using SignalP v3.0 (Table 3) predicted the presence of cleavage sites for bacterial signal 
peptidases, 10 commonly expressed proteins (i.e PotF, GltI, ArgT, Cbp, OmpW, DUF3315, periplasmic amino acid 
binding transport protein, extracellular ligand binding protein, phosphate transport system substrate-binding 
exported periplasmic protein, hypothetical protein BPSL1125) were predicted as secretory proteins of the clas-
sical Sec pathway. As expected, SignalP was predicted to present on the protein located in the outer membrane 
and the extracellular proteins. However, the TMHMM v2.0 algorithm predicted phosphate transport system 
substrate-binding exported periplasmic protein as integral membrane-associated proteins with only one helix 
(Table 3).
Figure 2. Analysis of BpMARAN and Bpmouse-adapted whole bacterial protein by 2-DE. The whole bacteria of 
BpMARAN (panel A) and Bpmouse-adapted (panel B) grown to mid-logarithmic phase in LB medium were prepared 
using sonication method and analysed using 2-DE. A total of 450 μg of whole bacteria was separated on an IPG 
strip pH 3–10 in the first dimension, followed by the separation on SDS-12% PAGE for the second-dimension 
separation. The separated proteins were detected by CBB G-250 staining. Marked spots indicate proteins 
that were identified (red: up-regulated; and green: down-regulated). NS refers to spots that were not possibly 
identified by MALDI-TOF.
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Functional category and 
Protein namea Spot
Anova 
(p-value) Locus tagb
Fold 
change
Sequence 
coverage(%)
Theo/exp 
MW
Theo/exp 
pI SignalPd TMHMMf Subcellular locationc
Metabolism
Energy production and conversion
F0F1 ATP synthase subunit 
alpha (atpA) 10 0.003 BPSL3398 2.0 20 55891/55781 5.48/5.48 − − cytoplamic
Betaine aldehyde dehydrogenase 
(alededh) 11* 6.15E-04 BPSL1550 3.2 30 50453/50353 5.67/5.67 − − cytoplamic
Isocitrate lyase (aceA) 12 0.042 BPSL2188 2.0 12 52238/47644 7.68/5.73 − − cytoplamic
Pyrophosphatase (ppa) 52* 0.026 BPSL1021 2.5 23 19149/19030 5.37/5.37 − − cytoplamic
Isocitrate dehydrogenase (idhI) 77 0.043 BPSL0896 2.0 24 46116/46015 5.76/5.63 − − unknown
F0F1 ATP synthase subunit beta 
(atpD) 83 0.013 BPSL3396 2.0 21 50417/50492 5.24/5.26 − − cytoplamic
F0F1 ATP synthase subunit beta 
(atpD) 84 0.018 BPSL3396 2.0 20 50147/50492 5.24/5.26 − − cytoplamic
Succinate dehydrogenase Iron-
sulfur subunit (sdhB) 85 0.007 BPSS1717 2.0 21 26776/26633 6.00/6.00 − − cytoplamic membrane
Amino acid transport and metabolism
Extracellular ligand binding 
protein (livK) 16* 0.004 BPSS0802 12.2 34 38875/39791 8.75/9.17 + − periplasmic
Putrescine-binding periplasmic 
protein (potF) 17* 0.017 BPSL1555 3.9 23 40171/40035 9.03/9.03 + − periplasmic
Periplasmic amino acid binding 
transport protein (livK) 18 0.038 BPSL3388 5.1 21 39974/39897 9.03/9.03 + − periplasmic
Argininosuccinate synthase 
(argG) 80 0.022 BPSL0298 2.0 24 49666/49566 5.375.37 − − cytoplamic
Arginine deiminase (arcA) 81 0.002 BPSL1743 2.1 32 46851/45921 5.40/5.57 − − cytoplamic
N-acetyl-gamma-glutamyl-
Phosphate reductase (argC) 86* 0.005 BPSL3246 2.0 23 33676/33566 6.60/6.61 − − cytoplamic
Carbohydrate and metabolism
Phosphopyruvate hydratase 
(eno) 14 0.049 BPSL2270 2.0 11 45656/45552 4.78/4.81 − − cytoplamic
Glyceraldehyde 3-phosphate 
dehydrogenase 1 (gapA) 28 0.03 BPSL2952 2.0 32 36082/35987 6.37/6.37 − − cytoplamic
Coenzyme metabolism
S-adenosylmethionine 
synthetase (metK) 82* 2.31E-04 BPSL0212 3.7 16 42615/42510 5.13/5.13 − − cytoplamic
Lipid metabolism
Beta-ketoadipyl CoA thiolase 
(paaJ) 29* 3.30E-04 BPSL3042 9.5 17 42285/42152 6.26/6.55 − − cytoplamic
Succinyl-CoA:3-ketoacid-
coenzyme A transferase subunit 
A (scoA)
58 0.039 BPSL1955 2.0 20 25230/25087 5.56/5.55 − − cytoplamic
Succinyl-CoA:3-ketoacid-
coenzyme A transferase subunit 
B (scoB)
67 0.048 BPSL1954 2.0 17 22273/22156 4.70/4.70 − − cytoplamic
Inorganic ion transport and metabolism
Catalase-peroxidase (katG) 5* 0.002 BPSL2865 2.6 7 79339/81630 5.66/5.89 − − cytoplamic
Catalase-peroxidase (katG) 6* 0.029 BPSL2865 3.8 6 79339/81630 5.66/5.89 − − cytoplamic
Phosphate transport system, 
substrate-binding exported 
periplasmic protein (pstS)
20 0.031 BPSL1359 2.0 26 35762/36230 8.89/9.01 + − periplasmic
Secondary metabolites biosynthesis, transport and catabolism
Non-ribosomally encoded 
peptide/polyketide synthase 
(phyH)
75 0.004 BPSS1183 2.0 24 39771/35275 7.73/5.77 − − cytoplamic
Cellular Processes
Cell wall/membrane/envelope biogenesis
Cell division protein (FtsZ) 15 0.008 BPSL3020 2.0 22 41574/41469 4.87/4.86 − − cytoplamic
Outer membrane protein 
(ompW) 31* 0.003 BPSL1552 3.1 17 22749/22632 8.60/8.60 + − outer membrane
Post-translation modification and chaperones
Molecular chaperone (DnaK) 1 0.013 BPSL2827 2.9 15 69700/69571 4.66/4.93 − − cytoplamic
Chaperonin (GroEL) 2 0.009 BPSL2697 2.1 38 57080/56985 5.13/5.13 − − cytoplamic
ClpB heat-shock protein 4* 0.005 BPSL1484 2.2 9 95991/97147 5.66/5.66 − − cytoplamic
Chaperonin (GroEL) 27 0.021 BPSL2697 4.3 23 57486/56985 5.13/5.13 − − cytoplamic
Continued
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The putative functions of the differentially expressed proteins. The identified proteins were ana-
lysed using COGs database to investigate the putative functions of the differently expressed proteins (Fig. 4). We 
predicted that majority of the up-regulated proteins (60.66%) were involved in metabolism [energy production 
(n = 8), amino acid transport (n = 13), carbohydrate transport (n = 4), coenzyme transport (n = 1), lipid trans-
port (n = 5), inorganic ion transport (n = 3) and secondary metabolites biosynthesis/transport/and catabolism 
(n = 3)]. About 24.59% of the up-regulated proteins were involved in cellular processing and signal [cell wall/
membrane/envelope biogenesis (n = 3), post-translational modification/protein turnover/chaperones (n = 6), 
and signal transduction mechanisms (n = 6)]. The remaining 6.56% and 8.20% were corresponding to informa-
tion storage and processing and poorly characterised proteins, respectively.
In contrast, majority of the down-regulated proteins (38.30%) were involved in cellular processing and sig-
nal [cell wall/membrane/envelope biogenesis (n = 1), post-translational modification/protein turnover/chaper-
ones (n = 11), and signal transduction mechanisms (n = 6)] and 23.40% were involved in information storage 
and processing [translation/ribosomal structure/and biogenesis (n = 9), and transcription (n = 2)]. Proteins 
that are poorly characterized were 19.15% (n = 9) and those involved in metabolism were only 19.15% (n = 9). 
Protein moonlighting (playing multiple unrelated functions) was also observed from several of the differentially 
expressed proteins; namely lysine-arginine-ornithine transport system, binding exported protein and glutamate/
aspartate periplasmic binding protein (signal transduction mechanisms and amino acid transport and metab-
olism), chain A crystal structure of putative exported protein (cell wall/membrane/envelope biogenesis and 
carbohydrate transport and metabolism) and response regulator protein (signal transduction mechanisms and 
transcription). Acetoacetyl-CoA reductase and acetyacetyl-CoA reductase were also protein that moonlights hav-
ing dual protein functions as secondary metabolites biosynthesis transport and catabolism, and general function 
prediction. Overall, there was a vast different, in term of the putative functional groups among the proteins that 
were differentially regulated between BpMARAN and Bpmouse-adapted.
Functional category and 
Protein namea Spot
Anova 
(p-value) Locus tagb
Fold 
change
Sequence 
coverage(%)
Theo/exp 
MW
Theo/exp 
pI SignalPd TMHMMf Subcellular locationc
Chaperonin (GroEL) 68 0.041 BPSL2697 2.2 19 57080/56985 5.13/5.13 − − cytoplamic
Chaperonin (GroEL) 72* 0.042 BPSL2697 2.0 18 57486/56985 5.13/5.13 − − cytoplamic
Information Storage And Processing
Translation, ribosomal structure and biogenesis
Ribosome recycling factor (frr) 22 0.039 BPSL2156 2.0 14 20886/20990 7.88/7.88 − − cytoplamic
50 S ribosomal protein L9 (rplI) 30 0.041 BPSL1461 2.1 50 16235/16114 6.85/6.85 − − cytoplamic
Elongation factor Tu (tuf) 79 0.037 BPSL3215 2.0 25 42964/42860 5.36/5.34 − − cytoplamic
Transcription
DNA-directed RNA polymerase 
subunit alpha (rpoA) 76 0.048 BPSL3187 2.0 24 35663/35554 5.76/5.76 − − cytoplamic
Poorly Characterised
Function unknown
Hypothetical protein BPSS0837 
(usp) 25 0.019 BPSS0837 2.8 16 29814/29832 8.04/8.05 − − unknown
Chitin-binding protein (cpbD) 26 0.048 BPSS0493 3.0 8 39260/39153 8.59/8.59 + − extracellular
BPSL0348 (pixA) 66* 0.042 BPSL0348 2.3 43 20170/27756 4.55/6.59 − − unknown
Moonlighting proteins
Amino acid transport and metabolism/Signal transduction mechanisms
Glutamate/aspartate periplasmic 
binding protein (gltI) 19 0.038 BPSL2924 2.9 33 32699/31300 9.17/9.17 + − periplasmic
Lysine-arginine-ornithine 
transport system, binding 
exported protein (argT)
24 0.044 BPSS0269 2.0 16 27833/28350 7.64/8.61 + − periplasmic
Secondary metabolites biosynthesis, transport and catabolism/General function prediction
Acetyacetyl-CoA reductase 
(phbB) 32 0.036 BPSL1536 2.5 22 26722/26377 6.84/6.84 − − cytoplamic
Acetoacetyl-CoA reductase 
(phbB) 33 0.042 BPSS1916 2.1 26 26408/26298 6.60/6.30 − − cytoplamic
Carbohydrate and metabolism/Cell wall/membrane/envelope biogenesis
Chain A, crystal structure 
of putative exported protein 
(wcaG)
23 0.039 − 2.0 27 25261/25582 8.41/8.12 − − unknown
Table 2. Identification of Burkholderia pseudomallei soil isolate, BpMARAN, up-regulated proteins in National 
Centre for Biotechnology (NCBI) non-redundant sequence using Mascot search engine data from MALDI-
TOF mass spectrometry. *Missing proteins in Bpmouse-adapted. aFunctional category based on Clusters of 
Orthologous Groups (COG) of protein. bLocus tag obtained from Burkholderia Database. cSubcellular location 
predicted using the PSORT analysis. dPresence of signal peptide predicted by SignalP server v. 3.0. eNumber of 
predicted transmembrane helices in protein using TMHMM server v. 2.0.
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Pathways analysis of the differentially expressed proteins. To further analyse the putative func-
tional roles of those differently expressed proteins, we included the KEGG pathway analysis (Table 4). Majority 
of the up-regulated pathways were found to be involved in metabolic functions, including microbial metabolism 
in diverse environments, glyoxylate and dicarboxylate metabolism, oxidative phosphorylation (energy metabo-
lism) and butanoate metabolism (carbohydrate metabolism). Apart from that, several other pathways were also 
up-regulated, namely, ABC transporters (membrane transport - environmental information processing) and 
RNA degradation (folding, sorting and degradation - genetic information processing).
In contrast, several amino acid metabolism pathways were down-regulated, namely, 2-oxocarboxylic acid 
metabolism, biosynthesis of amino acids, lysine biosynthesis, arginine and proline metabolism. Apart from 
that, two-component system, which is involved in signal transduction (environmental information processing), 
RNA degradation (folding, sorting and degradation - genetic information processing) were also found to be 
down-regulated.
Validation of the microarray data. The qRT-PCR assay was used for validation of ompW, groL, EF-Tu, 
extracellular ligand binding protein, katG, Hsp, hypothetical protein BPSS1107, BPSL1958 and BPSL0348 genes, 
which were differentially expressed in the proteomics analysis. The data obtained, together with those determined 
by the proteomic experiments are shown in Fig. 5. The gene expressions obtained using the two techniques were 
comparable. However, differences were observed in the fold-change values whereby the fold-change detected in 
qRT-PCR assay was higher than the protein expression.
Discussion
Our study has demonstrated differential protein expression of B. pseudomallei isolated from soil and the same 
isolate subsequently passaged and harvested from the mice tested in the same laboratory growth condition. 
Comprehensive knowledge of the proteins expressed by B. pseudomallei during in vivo growth in the host is 
essential to understand the pathogenesis of infectious diseases and symbiotic process. During the infection pro-
cess, B. pseudomallei are tackled with various stress factors including, nutrient starvation, antibiotics, heat/cold 
shock responses, and is presumably exposed to a variety of anti-bacterial factors such as complement, antibody, 
and phagocytes (which if activated, can obstruct progress of the bacteria to invade and infect the host).
Being a versatile intracellular bacteria, B. pseudomallei, would deliver its virulence factors into the host cells, 
depending on the close contact between the bacteria and the host23. On the other hand, the host is predisposed to 
exposure to the bacteria and counter-attack by the releasing immune responses24. Ultimately, this phenomenon 
alters the B. pseudomallei proteins expression to enable survival and persistence in the host under any extreme 
conditions. Thus, in order to identify the proteins associated with B. pseudomallei during colonisation in mice, we 
used 2-dimensional gel electrophoresis (2-DE) to analyse the whole bacterial proteins extracted from B. pseudom-
allei isolated from soil and the mouse-passaged homolog, which mimics an in vivo condition during infection. In 
addition, we also characterised different virulence factors of these strains including the ability to adhere, invade 
and capacity to produce biofilm.
Many studies have demonstrated the ability of clinical and environmental isolates of B. pseudomallei to adhere 
and invade into the cultured epithelial cells in vitro25–27. Our finding suggested that the adherence and invasive 
abilities of mice adapted B. pseudomallei isolate was clearly different than its counterpart B. pseudomallei soil 
isolate, although the growth of both strains was increasing in a similar pattern. The percentage of adherence 
and invasion of Bpmouse-adapted was noticeably higher than the BpMARAN and these differences may be attributed 
to the alteration in the adhesions proteins upon exposure to the host immune system. Collectively, it was evi-
dent that the Bpmouse-adapted was more virulent and possess higher pathogenic potential compared to its counter-
part the BpMARAN. Similar findings have also been reported in Helicobacter pylori by Zhang et al.28, whereby the 
Figure 3. Subcellular localisation of differently expressed BpMARAN and Bpmouse-adapted proteins. The subcellular 
localisation categories were predicted using PSORT.
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Functional category and 
Protein namea
Spot 
(p-value) Anova tagb
Locus 
change Fold
Sequence 
coverage (%) Theo/exp MW Theo/exp pI SignalPd TMHMMf
Subcellular 
locationc
Metabolism
Energy production and conversion
Quinone oxidoreductase 
(qor) 87 0.012 BPSL1169 −2.1 13 34706/34598 6.97/6.25 − − cytoplamic
Amino acid transport and metabolism
Acetylornithine transaminase 
(argD) 57 0.002 BPSL0926 −2.0 19 42851/42761 5.55/5.55 − − cytoplamic
Lipid metabolism
Enoyl-CoA hydratase (paaG) 73 0.011 BPSL3043 −2.5 33 28383/28269 5.31/5.32 − − cytoplamic
Inorganic ion transport and metabolism
Superoxide dismutase (sodB) 56 0.036 BPSL0880 −2.0 15 21159/21013 5.74/5.74 − − periplasmic
Secondary metabolites biosynthesis, transport and catabolism
Catechol 1,2-dioxygenase 
(catA) 78 0.001 BPSS1892 −6.1 32 32947/32836 5.62/5.62 − − cytoplamic
Cellular Processe
Post-translation modification and chaperones
Trigger factor (tig) 8 0.037 BPSL1402 −2.0 28 49708/49637 5.00/5.00 − − cytoplamic
Chaperonin (GroES) 41 0.021 BPSL2698 −2.3 12 10484/10359 5.78/5.79 − − cytoplamic
Hydroperoxide reductase 
(AhpC) 48 0.004 BPSL2096 −2.4 30 20322/20174 5.05/5.05 − − cytoplamic
Heat shock protein 20 (Hsp) 49 8.92E-04 BPSS2288 −2.3 22 15716/15895 5.14/5.14 − − unknown
Chaperonin (GroEL) 53 0.043 BPSL2697 −3.0 16 57486/56985 5.13/5.13 − − cytoplamic
Molecular chaperone DnaK 54* 0.003 BPSL2827 −3.5 8 69659/69571 4.94/4.93 − − cytoplamic
Heat shock protein 20 (Hsp) 61 5.54E-05 BPSS2288 −4.8 22 15716/15895 5.14/5.14 + + unknown
Heat shock protein 20 (Hsp) 62* 0.004 BPSS2288 −6.9 22 15716/15895 5.14/5.14 − − unknown
Heat shock protein 20 (Hsp) 63 0.015 BPSS2288 −6.4 22 15716/15895 5.14/5.14 − − unknown
Heat shock protein 20 (Hsp) 65 6.33E-04 BPSS2288 −5.0 26 15716/15895 5.14/5.14 − − unknown
Chaperonin (GroEL) 70 0.003 BPSL2697 −2.3 19 57080/56985 5.13/5.13 − − cytoplamic
Signal transduction mechanisms
dksA/traR C4-type zinc 
finger family protein (dksA) 50 0.025 BPSL0205 −2.4 56 15972/15879 5.11/5.24 − − cytoplamic
Information Storage And Processing
Translation, ribosomal structure and biogenesis
30S ribosomal protein S1 
(rpsA) 3 0.049 BPSL2515 −2.0 62300/62177 4.82/5.08 − − cytoplamic
PTS system, EIIA component 
(yhbH) 34 0.018 BPSL0532 −3.0 26 13668/13534 6.49/6.49 − − cytoplamic
Elongation factor Tu (tuf) 35 0.02 BPSL3215 −2.1 12 42964/42860 5.36/5.34 − − cytoplamic
Elongation factor Tu (tuf) 37 0.047 BPSL3215 −2.2 10 42907/42860 5.41/5.34 − − cytoplamic
Elongation factor Tu (tuf) 44* 0.003 BPSL3215 −3.8 8 43597/42860 5.36/5.34 − − cytoplamic
Elongation factor Tu (tuf) 45* 0.001 BPSL3215 −3.6 8 43597/42860 5.36/5.34 − − cytoplamic
Elongation factor Tu (tuf) 60* 3.81E-04 BPSL3215 −5.2 7 43090/42860 5.36/5.34 − − cytoplamic
Elongation factor Tu (tuf) 64 0.005 BPSL3215 −4.2 8 4359742860 5.42/5.34 − − cytoplamic
Elongation factor Tu (tuf) 74 0.001 BPSL3215 −6.1 10 42953/42860 5.41/5.34 − − cytoplamic
Transcription
Cold shock-like protein (csp) 42 0.005 BPSL0898 −4.8 14 7217/7090 6.54/6.54 − − cytoplamic
Poorly characterised
General function prediction
Hypothetical protein 
BPSS1924 (osmY) 51 0.012 BPSS1924 −2.3 18 20941/23037 5.68/5.31 − − cytoplamic
Function unknown
Hypothetical protein 
BPSL1125 (DUF3315) 36 0.002 BPSL1125 −2.5 24 28032/13628 10.28/9.15 + − unknown
Hypothetical protein 
BPSL1125 (DUF3315) 38 0.041 BPSL1125 −2.3 6 28032/13628 10.28/9.15 + − unknown
Hypothetical protein 
BPSL1406 39 0.02 BPSL1406 −2.3 33 12347/12224 6.90/6.91 − − cytoplamic
Hypothetical protein 
BPSL1125 (DUF3315) 40 0.003 BPSL1125 −4.2 19 28032/13628 10.28/9.15 + − unknown
Phasin−like protein (phaP) 47 0.039 BPSL2298 −3.2 38 19861/19742 5.96/5.96 − − periplasmic
Continued
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mice-adapted strain demonstrated higher ability to adhere and invade into host cells compared to the counterpart 
strains. However, both the strains were found to produce biofilm at both 30 °C (soil temperate) and 37 °C (host 
temperature). Significant differences were observed in biofilm formation at 37 °C whereby, lower biofilm in the 
Bpmouse-adapted strain as compared with the soil strain (BpMARAN). This could be due to stress caused by adaptation 
and compromise with the host immune responses.
To further investigate the altered proteins, we therefore performed 2-DE of BpMARAN and Bpmouse-adapted whole 
bacterial proteins which were collected during the mid-logarithmic phase, when the bacterial cells are actively 
dividing. Interestingly, there was a slight difference in the number of proteins spots detected between both the 
strains. The number of protein spots identified in Bpmouse-adapted was comparatively lower than the protein spots 
identified in its homolog counterpart strain. Several unique proteins were also found to be present in both the 
strains. This clearly demonstrates that the differences may be attributed to the variations of the bacterial protein 
modulations upon host-adaptation. In addition, several proteins involved in adherence and invasion were found 
to be up-regulated in the Bpmouse-adapted. Taken together these findings may indicate the contribution of the differ-
entially expressed proteins to the ability of the strains to adhere and invade into host cells.
In our present study, the 2-DE protein profiles revealed a total of 87 protein spots that were differentially 
expressed between the B. pseudomallei BpMARAN and Bpmouse-adapted. Of that, 44 spots were found to be up-regulated 
and 43 were down-regulated. In general, majority of the proteins altered following direct interaction with the 
hosts were involved in metabolic functions. This could be due to the ability of B. pseudomallei to adjust the 
metabolic pathways in order to exploit nutrients from the host during the infection cycle and intracellular sur-
vival lifestyle29, 30. Several transportation and conversion of energy production, carbohydrate, lipid, coenzymes, 
inorganic ions and secondary metabolites systems may be vital for the survival of B. pseudomallei. Additionally, 
Stark et al.31 also found that those proteins identified in uptake of amino acids transporters were also seems to 
be essential during infection process of H. pylori. Thus, these may suggest that not only carbohydrate, but also 
amino acids could be obtainable as carbon source for energy consumption at certain point of infection as pri-
mary source of energy is scarce when B. pseudomallei undergoes metabolic stress32. Our results also revealed 
that the Bpmouse-adapted had a restricted glycolysis/gluconeogenesis and increased in BpMARAN. Similarly, a compar-
ative proteomic study between Brucella suis (grown in rich media) and post-infected in J774 macrophages by Al 
Dahouk and co-workers33 demonstrated 44 differently expressed proteins involved in primary metabolism which 
is strictly needed for survival. Reduction of the metabolic pathways in Bpmouse-adapted suggests that there may be 
limited sugar supply during the infection process. This in turn may aid in the persistence of the pathogen since by 
reducing or limiting the metabolic functions, it may be able to avoid recognition of the host immune system. In 
addition, the induction of proteins involved in oxidative phosphorylation suggested the use of alternative path-
ways for energy production34.
Although metabolic proteins are known to play major functions in energy production for survival, it has also 
been suggested that they play a role in virulence35. In this study, we also found that several proteins involved 
in virulence and persistence were significantly altered between the BpMARAN and Bpmouse-adapted. Expression of 
virulence proteins are usually controlled by signalling pathways and regulatory mechanism which is typically 
similar to those proteins that are indistinct to pathogenesis. It is often based on the reversible phosphorylation 
proteins, particularly the two-component regulatory system (consist of membrane-bound histidine kinase and 
response regulator) and phosphoenolpyruvate phosphotransfer system (PTS)36. In our study, the two-component 
system which facilitates B. pseudomallei to sense, respond, and adapt to changes in their environment or in their 
Functional category and 
Protein namea
Spot 
(p-value) Anova tagb
Locus 
change Fold
Sequence 
coverage (%) Theo/exp MW Theo/exp pI SignalPd TMHMMf
Subcellular 
locationc
Hypothetical protein 
BPSS1107 55* 0.003 BPSS1107 −2.5 19 17045/16924 5.73/5.73 − − cytoplamic
Hypothetical protein 
BPSL1958 69* 0.043 BPSL1958 −2.8 3 36088/35995 4.38/4.38 − − unknown
Hypothetical protein 
BPSS1924 (osmY) 71 0.042 BPSS1924 −2.0 13 20941/23037 5.68/5.31 − − cytoplamic
Moonlighting proteins
Amino acid transport and metabolism/Signal transduction mechanisms
Glutamate/aspartate 
periplasmic binding protein 
(gltI)
21 0.014 BPSL2924 −5.6 22 32699/35200 9.17/9.17 + − periplasmic
Secondary metabolites biosynthesis, transport and catabolism/General function prediction
Acetoacetyl-CoA reductase 
(phbB) 43 0.012 BPSS1916 −3.3 14 26408/26298 6.60/6.30 − − cytoplamic
Signal transduction mechanisms/Transcription
Response regulator protein 
(regA) 59 0.007 BPSL0202 −2.3 41 19769/19800 5.82/5.83 − − cytoplamic
Table 3. Identification of Burkholderia pseudomallei soil isolate, BpMARAN, down-regulated proteins in National 
Centre for Biotechnology (NCBI) non-redundant sequence using Mascot search engine data from MALDI-
TOF mass spectrometry. *Missing proteins in BpMARAN. aFunctional category based on Clusters of Orthologous 
Groups (COG) of protein. bLocus tag obtained from Burkholderia Database. cSubcellular location predicted 
using the PSORT analysis. dPresence of signal peptide predicted by SignalP server v. 3.0. eNumber of predicted 
transmembrane helices in protein using TMHMM server v. 2.0.
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intracellular state were found to be up-regulated in Bpmouse-adapted. Activation of the two-component response 
regulator may induce changes in the cellular physiology, by regulating expression of different genes37, and thus, 
enabling B. pseudomallei to sense and respond to stimuli by inducing changes in transcription and virulence, par-
ticularly in biofilm formation. The inactivation of the transposition may eventually lead to defects in attachment, 
invasion and survival38. Additionally, Tuanyok et al.32 have identified differentially expressed potential virulence 
genes involved in the putative two-component regulatory system, and have also provided a better understanding 
of B. pseudomallei to generate and maintain cellular energy in vivo in response to the host environment during 
acute melioidosis using hamster model. It was also suggested that the PTS supply the bacteria with integrated 
system that ensure optimal utilisation of carbohydrate in complex environments, a feature that is particularly 
important in host-pathogen interaction36.
Figure 4. Prediction of the functional protein categories of differently expressed BpMARAN and Bpmouse-adapted 
proteins. The identified proteins were assigned into functional classes of based on Cluster of Orthologous 
Groups (COG) and Gene Ontology (GO) for the proteins functional categories (metabolism, cellular processing 
and signal, information storage and processing and poorly characterised proteins). (red: up-regulated; green: 
down-regulated).
Condition KEGG pathway Number of gene (s)
Up-regulated
Metabolic pathways 14
Microbial metabolism in diverse 
environments 7
Oxidative phosphorylation 4
Butanoate metabolism 4
ABC transporters 5
Biosynthesis of secondary 
metabolites 9
Carbon metabolism 5
RNA degradation 3
Glyoxylate and dicarboxylate 
metabolism 2
Down-regulated
RNA degradation 3
Arginine and proline metabolism 2
2-Oxocarboxylic acid 
metabolism 2
Two-component system 3
Biosynthesis of amino acids 2
Lysine biosynthesis 2
Table 4. Identification of the significant pathways (p-value < 0.05) of differentially expressed proteins using 
KEGG pathway analysis.
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Apart from that, we also observed several proteins involved in virulence and/or persistence which were either 
absent or present in both BpMARAN and Bpmouse-adapted, particularly catalase/peroxidase (KatA). Lefebre et al.39 con-
clude that the catalase/peroxidase is has a novel function by contributing to maintain the normal activity of the 
tricarboxylic acid (TCA) cycle, and plays a global role in cellular protection against oxidative stress40. Modulation 
of outer membrane protein and several periplasmic transpoters were also observed, which may regulate homeo-
stasis and structure of the B. pseudomallei envelope. The observations underline the significance of crucial patho-
genesis of B. pseudomallei in terms of the interplay between bacterial counter-host immune mechanisms.
In summary, our results imply that both the host and the B. pseudomallei factors are involved in the development 
of the pathogenic outcome of infection. The identified proteins suggest differences in the pathogenic potentials of B. 
pseudomallei to infect and cause disease in man. Thus, this in vivo study provided a comprehensive description of the 
proteomic differences between the soil and mice-passaged B. pseudomallei, which is particularly imperative, since 
they revealed information that could not have been predicted using classic in vitro growth conditions.
Based on our analysis, the proteins that were differentially expressed between the B. pseudomallei soil strain 
and its mouse adaptive variant contributed to host colonisation and adaptation by modulating stress response, 
metabolism, virulence, and colonisation-associated proteins. The data on the role of these proteins in colonisation 
may highlight the importance of these proteins in the establishment of infection, provide information for the 
development of novel vaccine candidates, and indicate intervention modalities for the prevention or treatment of 
B. pseudomallei infections.
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